We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




3D Hydrogel Biochips Help Detect Bowel Cancer

By HospiMedica International staff writers
Posted on 06 Jun 2016
Print article
Image: The hydrogel-based biochip to help detect bowel cancer (Photo courtesy of MIPT.)
Image: The hydrogel-based biochip to help detect bowel cancer (Photo courtesy of MIPT.)
A novel three-dimensional (3D) hydrogel-based biochip containing molecular probes can help detect serological signatures in the sera of colorectal cancer (CC) patients.

Developed by researchers at the Moscow Institute of Physics and Technology (MIPT; Russia), the Engelhardt Institute of Molecular Biology (EIMB; Moscow, Russia), and a number of other Russian research centers, the glycochip contains an array of hemispherical hydrogel cells containing immobilized proteins and oligosaccharides that can help detect tumor-associated glycans.

Besides detecting a range of antibodies against glycans (SiaTn, Tn, TF, LeC, LeY, SiaLeA, and Manβ1-4GlcNAcβ), the glycochip also contains antibodies against human immunoglobulins (IgG, IgA, and IgM). The simultaneous measurement of the levels of immunoglobulins in sera enhances the diagnostic impact of the signatures. To test the glycochips, the researchers studied 69 sera samples from healthy donors, 33 from patients with CC, and 27 from patients with inflammatory bowel diseases.

The results showed that the positive predictive value of the test system, based on the diagnostic signatures, allowed it to diagnose CC in 95% of the cases, compared to around 79% detected by traditional methods. The sensitivity of detection (in patients with Stage II-IV CC) was 87%, compared to just 21% by traditional methods. The specificity of the method was 97%. The study was published on March 19, 2016, in Cancer Medicine.

“The method developed at EIMB RAS has great potential to be used in diagnosing gastrointestinal diseases,” said study co-author Zhanna Zubtsova, PhD, an assistant professor in the physics department at MIPT. “We hope that testing systems based on the method will soon appear in clinical laboratories in Russia.”

Glycans are biopolymers consisting of a large number of monosaccharides linked by oxygen atoms. Besides acting as nutrients and building materials for cells, glycans are important for the contact between cells, appropriate organ growth, and much more. Tumor cells hold special glycans that help differentiate them from healthy cells, a key aspect of the new study.

Related Links:
Moscow Institute of Physics and Technology
Engelhardt Institute of Molecular Biology
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
Surgial Headlight
MedLED Chrome

Print article

Channels

Surgical Techniques

view channel
Image: NTT and Olympus have begun the world\'s first joint demonstration experiment of a cloud endoscopy system (Photo courtesy of Olympus)

Cloud Endoscopy System Enables Real-Time Image Processing on the Cloud

Endoscopes, which are flexible tubes inserted into the body's natural openings for internal examination and biopsy collection, are becoming increasingly vital in medical diagnostics. Their minimal invasiveness... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The PATHFAST hs-cTnI-II high-sensitivity troponin assay has been developed for the PATHFAST Biomarker Analyzer (Photo courtesy of Polymedco)

POC Myocardial Infarction Test Delivers Results in 17 Minutes

Chest pain is the second leading cause of emergency department (ED) visits by adults in the United States, generating over 7 million visits annually. In the event of a suspected heart attack, physicians... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.